Karuna Therapeutics (KRTX) Enterprise Value
Price: $329.83
Market Cap: $12.60B
Avg Volume: 971.83K
Market Cap: $12.60B
Avg Volume: 971.83K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to Karuna Therapeutics's latest quarterly financial reports:
- The enterprise value (EV) is 11.79B, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 11.70B, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $316.51, with 37.78M shares outstanding.
- The company has 185.82M in cash and cash equivalents and 16.69M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$11.79B
Market Cap
$11.96B
Total Debt
$16.69M
Cash and Equivalents
$185.82M
Historical Enterprise Value
Karuna Therapeutics Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2023-12-31.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| December 31, 2023 | $11.79B | 90.02% | $316.51 | 37.78M | $11.96B | $185.82M | $16.69M |
| September 30, 2023 | $6.20B | -21.36% | $169.09 | 37.69M | $6.37B | $184.47M | $15.61M |
| June 30, 2023 | $7.89B | 36.89% | $216.85 | 37.52M | $8.14B | $263.60M | $15.81M |
| March 31, 2023 | $5.76B | -11.58% | $181.64 | 34.80M | $6.32B | $562.66M | $4.76M |
| December 31, 2022 | $6.52B | -2.04% | $196.5 | 34.41M | $6.76B | $248.33M | $5.33M |
| September 30, 2022 | $6.65B | 82.17% | $224.93 | 32.35M | $7.28B | $628.32M | $5.89M |
| June 30, 2022 | $3.65B | 1.18% | $126.51 | 29.90M | $3.78B | $136.10M | $6.44M |
| March 31, 2022 | $3.61B | -2.17% | $126.79 | 29.81M | $3.78B | $176.20M | $6.98M |
| December 31, 2021 | $3.69B | 9.38% | $131 | 29.69M | $3.89B | $206.95M | $7.50M |
| September 30, 2021 | $3.37B | 11.57% | $122.33 | 29.57M | $3.62B | $252.22M | $8.02M |
| June 30, 2021 | $3.02B | 1.13% | $113.99 | 29.48M | $3.36B | $345.65M | $8.40M |
| March 31, 2021 | $2.99B | 11.52% | $120.23 | 27.79M | $3.34B | $353.69M | $2.48M |
| December 31, 2020 | $2.68B | 32.73% | $101.59 | 26.88M | $2.73B | $53.05M | $2.69M |
| September 30, 2020 | $2.02B | -27.54% | $77.32 | 26.66M | $2.06B | $44.79M | $2.88M |
| June 30, 2020 | $2.79B | 65.22% | $111.46 | 26.19M | $2.92B | $133.87M | $2.62M |
| March 31, 2020 | $1.69B | 3.39% | $72 | 26.04M | $1.88B | $190.65M | $2.75M |
| December 31, 2019 | $1.63B | 410.07% | $75.34 | 24.43M | $1.84B | $208.93M | $208.00K |
| September 30, 2019 | $319.92M | -4057.67% | $16.32 | 22.91M | $373.85M | $54.14M | $220.00K |
| June 30, 2019 | $-8.08M | -102.35% | $21 | 103.68K | $2.18M | $10.49M | $234.00K |
| March 31, 2019 | $343.82M | 160.27% | $20.02 | 21.37M | $427.89M | $84.28M | $212.00K |
| December 31, 2018 | $132.10M | -39.27% | $20.02 | 10.87M | $217.52M | $85.53M | $102.00K |
| September 30, 2018 | $217.52M | 0.00% | $20.02 | 10.87M | $217.52M | $- | $- |
| June 30, 2018 | $217.52M | 0.00% | $20.02 | 10.87M | $217.52M | $- | $- |
| March 31, 2018 | $217.52M | - | $20.02 | 10.87M | $217.52M | $- | $- |
Related Metrics
Explore detailed financial metrics and analysis for KRTX.